Aerogen has received a receipt from the State Food and Drug Administration (SFDA) to commercialize its Aeroneb Pro and Aeroneb Go products.

The Aeroneb Pro, which utilizes a patented vibrating mesh technology, is a multi-patient nebuliser creating a fine particle aerosol for targeted drug delivery to the lungs to treat a broad spectrum of patient respiratory conditions.

Aeroneb Go which also uses the same vibrating technology is used for inhaled drug treatment in the home.

Gaelmed, a distribution partner of Aerogen, will sell Aeroneb Pro and the Aeroneb Go within China.